Qiukai Lu

机构：Chinese Academy of Sciences, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences

发表论文 11 篇 · 总被引 435 次 · h-index 9

代表论文

• STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion (2021 · Acta Pharmacologica Sinica · 被引 137)
• Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis (2020 · Cell Death and Disease · 被引 82)
• Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis (2021 · Acta Pharmaceutica Sinica B · 被引 48)
• Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment (2020 · European Journal of Medicinal Chemistry · 被引 37)
• Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders (2022 · Pharmacological Reports · 被引 36)
• Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis (2024 · Inflammatory Bowel Diseases · 被引 35)